Sea Otter Advisors’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Sea Otter Advisors’s Portfolio BIOT Stock Details BIOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,000	Closed	-$151K	–	307
2022 Q4	$151K	Buy	+15,000	New	+$150K	0.23%	61

Sea Otter Advisors's BIOT Position: Q1 2023 in Review

Sea Otter Advisors sold out of Biotech Acquisition Company Class A Ordinary Shares (BIOT) in Q1 2023, closing a stake of 15,000 shares — an estimated $151K sold.

Sea Otter Advisors first reported a position in BIOT in Q4 2022 and held it in 1 quarter. The position peaked at $151K in Q4 2022. 0 funds tracked by Wall St. Rank hold BIOT as of Q1 2023.

Sea Otter Advisors reported no remaining Biotech Acquisition Company Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Sea Otter Advisors sold 15,000 Biotech Acquisition Company Class A Ordinary Shares shares in Q1 2023, an estimated $151K.
Sea Otter Advisors first reported a position in Biotech Acquisition Company Class A Ordinary Shares in Q4 2022 and held it in 1 quarter.
Sea Otter Advisors's Biotech Acquisition Company Class A Ordinary Shares position peaked at $151K in Q4 2022.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Class A Ordinary Shares as of Q1 2023.

Based on Sea Otter Advisors's 13F filing for Q1 2023, filed 15 May 2023.